Movement Alert｜INSILICO Falls 8.68% in Regular Trading, AI Pharma Sector Undergoes Collective Pullback

Market Focus

8 hours ago

On October 7, INSILICO fell 8.68% in regular trading, trading at 54.85 HKD/share, with turnover of 56.0542 million HKD. The decline occurred amid a broader pullback in AI pharmaceutical stocks, despite the company's recent strong pipeline progress.

INSILICO recently nominated ISM1354, a next-generation small-molecule GIPR antagonist, as a preclinical candidate for obesity and type 2 diabetes, marking its 10th PCC nomination in the first nine months of the year. The company's shares had risen over 8% on September 30 following this announcement, reaching 59.95 HKD at close. However, short-term volatility in the sector has since intensified, with peers including GENSCRIPT BIO and XTALPI also declining sharply in the current session.

The company operates an AI-driven drug discovery platform, Pharma.AI, which has generated multiple clinical and IND-stage assets. Its pipeline includes Rentosertib, currently in Phase III trials for idiopathic pulmonary fibrosis.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1157208491"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157208491\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157208491?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-07 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157208491","market":"us","top_or_hot":-1,"title":"Movement Alert｜INSILICO Falls 8.68% in Regular Trading, AI Pharma Sector Undergoes Collective Pullback","media":"Market Focus","content":"<p><p>On October 7, INSILICO fell 8.68% in regular trading, trading at 54.85 HKD/share, with turnover of 56.0542 million HKD. The decline occurred amid a broader pullback in AI pharmaceutical stocks, despite the company's recent strong pipeline progress.</p><p>INSILICO recently nominated ISM1354, a next-generation small-molecule GIPR antagonist, as a preclinical candidate for obesity and type 2 diabetes, marking its 10th PCC nomination in the first nine months of the year. The company's shares had risen over 8% on September 30 following this announcement, reaching 59.95 HKD at close. However, short-term volatility in the sector has since intensified, with peers including GENSCRIPT BIO and XTALPI also declining sharply in the current session.</p><p>The company operates an AI-driven drug discovery platform, Pharma.AI, which has generated multiple clinical and IND-stage assets. Its pipeline includes Rentosertib, currently in Phase III trials for idiopathic pulmonary fibrosis.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜INSILICO Falls 8.68% in Regular Trading, AI Pharma Sector Undergoes Collective Pullback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜INSILICO Falls 8.68% in Regular Trading, AI Pharma Sector Undergoes Collective Pullback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-07 09:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 7, INSILICO fell 8.68% in regular trading, trading at 54.85 HKD/share, with turnover of 56.0542 million HKD. The decline occurred amid a broader pullback in AI pharmaceutical stocks, despite the company's recent strong pipeline progress.</p><p>INSILICO recently nominated ISM1354, a next-generation small-molecule GIPR antagonist, as a preclinical candidate for obesity and type 2 diabetes, marking its 10th PCC nomination in the first nine months of the year. The company's shares had risen over 8% on September 30 following this announcement, reaching 59.95 HKD at close. However, short-term volatility in the sector has since intensified, with peers including GENSCRIPT BIO and XTALPI also declining sharply in the current session.</p><p>The company operates an AI-driven drug discovery platform, Pharma.AI, which has generated multiple clinical and IND-stage assets. Its pipeline includes Rentosertib, currently in Phase III trials for idiopathic pulmonary fibrosis.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1157208491","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157208491","pubTimestamp":1791336832,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 7, INSILICO fell 8.68% in regular trading, trading at 54.85 HKD/share, with turnover of 56.0542 million HKD. The decline occurred amid a broader pullback in AI pharmaceutical stocks,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"走势提醒|INSILICO常规交易下跌8.68%，人工智能制药板块集体回调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On October 7, INSILICO fell 8.68% in regular trading, trading at 54.85 HKD/share, with turnover of 56.0542 million HKD. The decline occurred amid a broader pullback in AI pharmaceutical stocks, despite the company's recent strong pipeline progress.INSILICO recently nominated ISM1354, a next-generation small-molecule GIPR antagonist, as a preclinical candidate for obesity and type 2 diabetes, marking its 10th PCC nomination in the first nine months of the year. The company's shares had risen over 8% on September 30 following this announcement, reaching 59.95 HKD at close. However, short-term volatility in the sector has since intensified, with peers including GENSCRIPT BIO and XTALPI also declining sharply in the current session.The company operates an AI-driven drug discovery platform, Pharma.AI, which has generated multiple clinical and IND-stage assets. Its pipeline includes Rentosertib, currently in Phase III trials for idiopathic pulmonary fibrosis.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}